Journal article

COAGULATION ACTIVATION IN LIVER-DISEASES


Authors listKEMKESMATTHES, B; BLEYL, H; MATTHES, KJ

Publication year1991

Pages253-261

JournalThrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis

Volume number64

Issue number2

ISSN0049-3848

DOI Linkhttps://doi.org/10.1016/0049-3848(91)90124-F

PublisherElsevier


Abstract
In liver disorders alterations of the coagulation system are mainly due to a reduced synthesis of coagulation proteins. In addition, an enhanced intravascular consumption of coagulation factors is discussed controversely in liver diseases. By measuring factor IX(i)AT-and TAT-complexes we tried to find out, whether coagulation activation in liver patients leads to activation of the complete coagulation cascade followed by DIC or whether in some diseases a futile partial coagulation activation develops. In all liver diseases examined, elevated factor IX(i)AT-complexes were demonstrated, while TAT-complexes were only elevated in chronic active hepatitis, metabolic decompensated liver cirrhosis and in patients suffering from end stage liver disease. We conclude that all liver diseases examined lead to an activation of the coagulation cascade. A complete activation followed by DIC only occurs in patients with very severe liver disorders.



Citation Styles

Harvard Citation styleKEMKESMATTHES, B., BLEYL, H. and MATTHES, K. (1991) COAGULATION ACTIVATION IN LIVER-DISEASES, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis, 64(2), pp. 253-261. https://doi.org/10.1016/0049-3848(91)90124-F

APA Citation styleKEMKESMATTHES, B., BLEYL, H., & MATTHES, K. (1991). COAGULATION ACTIVATION IN LIVER-DISEASES. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis. 64(2), 253-261. https://doi.org/10.1016/0049-3848(91)90124-F



Keywords


CIRRHOSISCOAGULATION ACTIVATIONDEGRADATION PRODUCTFACTOR-IXIAT-COMPLEXFIBRINOGENFIBRINOPEPTIDE-AINTRAVASCULAR COAGULATIONLIVER DISEASETAT-COMPLEX

Last updated on 2025-02-04 at 06:08